Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Influx Healthtech Limited (NSE: INFLUX), ISIN INE0MYZ01012 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
INFLUX last traded at ₹283.00 (+2.74%), with a 52-week range of ₹160.60 to ₹315.00 (as of 23 Sep 2026).
Shareholding as of Mar 2026: promoters 73.53%, FIIs 0.16%, DIIs 5.65%, mutual funds 0.00%.
EquiSense Score (ECS): 87/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.